Mustang Bio, Inc.
MBIO
$0.59
$0.00-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.03M | -2.72M | -1.92M | -2.34M | -3.28M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 41.00K | 116.00K | 167.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -876.00K | -914.00K | -1.70M | -217.00K | -403.00K |
| Change in Net Operating Assets | -602.00K | -1.25M | -1.68M | -3.11M | -2.97M |
| Cash from Operations | -4.51M | -4.88M | -5.26M | -5.54M | -6.48M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 1.17M | 1.17M | 1.17M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 1.17M | 1.17M | 1.17M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.15M | 7.15M | 14.76M | 19.70M | 13.57M |
| Repurchase of Common Stock | -- | -235.00K | -235.00K | -235.00K | -235.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -141.00K | -- | -- | -- | -- |
| Cash from Financing | 7.00M | 6.91M | 14.53M | 19.46M | 13.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.49M | 2.03M | 10.43M | 15.08M | 8.01M |